NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa
Who’s Going to NSGC 2026
Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website
86 exhibitors and 18 sponsored symposia at the National Society of Genetic Counselors (NSGC) 45th Annual Conference, a ~2,500-person, mostly clinical meeting of genetic counselors in clinics, testing labs and industry. As of Nov 12, 2026.
| Organization | NSGC 2026 Attendance |
|---|---|
Ambry Genetics Aliso Viejo, CA | |
Clinical genetic testing laboratory, part of Tempus, offering hereditary cancer, rare disease and whole-genome testing with RNA analysis and automatic reanalysis. | Booth Exhibiting at Booth 1169 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Thu Nov 12 12:15–1:30pm Uncovering the Complete Picture: Transforming Rare Disease Care for Every Patient Shows how Ambry's clinical genome sequencing, RNA testing and automatic report reanalysis aim to raise diagnostic yield in rare disease. Hosts a sponsored reception for attendees, Thu Nov 12, 8–11pm |
Natera Austin, TX | |
Cell-free DNA testing laboratory offering prenatal screening (NIPT), carrier screening, oncology and transplant tests, and rare disease genetic testing. | Booth Exhibiting at Booth 1263 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 12:15–1:30pm Shifting the NIPT Paradigm: The Impact of Clinically Validated Accuracy at Low Fetal Fraction Presents validation data for Natera's updated Panorama prenatal screen at fetal fractions as low as 1%, and what it means for counseling. Symposium Thu Nov 12 7:45–8:30am Beyond the Report: Bridging the Gap Between Rare Disease Diagnosis and Clinical Trial Access Describes Natera's Zenith service, which matches patients' rare disease results to open clinical trials and alerts their clinicians. |
Acadia Pharmaceuticals San Diego, CA | |
Biopharmaceutical company with approved treatments for Rett syndrome and Parkinson's disease psychosis, developing further medicines for neurological and rare conditions. | Booth Exhibiting at Booth 963 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Fri Nov 13 7:45–8:30am Rett Syndrome Management Your Way: Two Formulations of the First and Only FDA-Approved Treatment Covers Rett syndrome care with both forms of Acadia's FDA-approved Rett treatment, DAYBUE and DAYBUE STIX. |
Alexion, AstraZeneca Rare Disease Boston, MA | |
AstraZeneca's rare disease company, with medicines for conditions including hypophosphatasia, lysosomal acid lipase deficiency, neurofibromatosis type 1 and complement disorders. | Booth Exhibiting at Booth 1155 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Fri Nov 13 12:15–1:30pm Recognize What Might Be Missed: Changing the Patient Journey in HPP, LAL-D, NF1 Reviews the clinical clues to hypophosphatasia, lysosomal acid lipase deficiency and neurofibromatosis type 1, to help clinicians recognize them earlier. |
Ascendis Pharma Copenhagen, Denmark | |
Biopharmaceutical company developing long-acting treatments for rare endocrine and skeletal conditions, including achondroplasia. | Booth Exhibiting at Booth 1055 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 7:45–8:30am Discover Yuviwel® (navepegritide) Introduces Ascendis' Yuviwel (navepegritide), covering how it works, its clinical trial results and how it is dosed. |
Baylor Genetics Houston, TX | |
Genetic testing laboratory, a joint venture with Baylor College of Medicine, offering genome, exome and panel testing from prenatal through adult care. | Booth Exhibiting at Booth 1376 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 12:15–1:30pm Reimagining Genomic Testing Across the Care Continuum (from Prenatal to Postnatal) Argues for genome-first prenatal testing and extra technologies beyond genome sequencing after birth, to find diagnoses that standard tests miss. |
BillionToOne Menlo Park, CA | |
Prenatal and cancer testing laboratory offering cell-free DNA prenatal screening, including fetal risk for recessive conditions, and liquid biopsy tests for oncology. | Booth Exhibiting at Booth 1469 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 7:45–8:30am Innovation with Intention: Advancing Prenatal Genetics Together Discusses what new prenatal screening technologies can and cannot do, and how testing companies and genetic counselors can work together. |
BioMarin San Rafael, CA | |
Biotech company with medicines for rare genetic conditions, including achondroplasia and other skeletal disorders, PKU and several lysosomal storage disorders. | Booth Exhibiting at Booth 1150, 1243, 1342 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Thu Nov 12 7:45–8:30am Hypochondroplasia: Advancing Diagnosis and Genetic Counseling in an Evolving Clinical Landscape Follows patients with hypochondroplasia from first suspicion to genetic confirmation and counseling, including FGFR3 variant interpretation and emerging treatments. |
BridgeBio Palo Alto, CA | |
Biotech company developing medicines for genetic conditions, including transthyretin amyloid cardiomyopathy and achondroplasia. | Booth Exhibiting at Booth 1247, 1347 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Fri Nov 13 7:45–8:30am One Diagnosis, Many Conversations: The Evolving Landscape of Care in Achondroplasia and the Role of Genetic Counselors Traces achondroplasia care from prenatal recognition through childhood treatment choices to adult family planning, and the genetic counselor's role throughout. |
Exact Sciences Madison, WI | |
Genetic testing company, now part of Abbott, offering germline exome and panel testing through its PreventionGenetics lab plus a multi-cancer early detection blood test. | Booth Exhibiting at Booth 1069 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 7:45–8:30am Decoding Multi-Cancer Early Detection (MCED) Testing: The Science and Evidence Behind the Cancerguard® Test Explains how Exact Sciences' Cancerguard multi-cancer early detection test combines DNA methylation and protein markers, and how to read its evidence. |
Clinical genetic testing laboratory focused on exome and genome sequencing for rare disease diagnosis, drawing on a large rare disease dataset. | Booth Exhibiting at Booth 969 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Wed Nov 11 12:15–1:30pm CSI: Clinical Sequencing Investigation: Applying Genomic Evidence to Solve the Case An escape-room-style case where attendees use phenotype clues, variant evidence and AI prioritization tools to reach a genomic diagnosis. |
Labcorp Burlington, NC | |
National clinical laboratory company, now including Invitae's genetic testing, offering diagnostics alongside drug development services. | Booth Exhibiting at Booth 1377 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Thu Nov 12 12:15–1:30pm The Next Wave: Preparing for the Age of Population Genomics as a Genetic Counselor Reviews the evidence for population genomic screening and how genetic counselors can support education, consent and follow-up as it grows. |
Lilly Indianapolis, IN | |
Global pharmaceutical company whose genetic medicine work includes gene therapy for hereditary hearing loss; sponsors a session on hearing loss genetic testing. | Booth Exhibiting at Booth 1363 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Fri Nov 13 7:45–8:30am Partners in Diagnosis: Collaborative Models for Genetic Testing and Counseling in Hereditary Hearing Loss Uses hereditary hearing loss to show how genetic counselors, audiologists and otolaryngologists can team up so genetic testing is routinely offered. |
Myriad Genetics Salt Lake City, UT | |
Genetic testing laboratory offering hereditary cancer risk testing, prenatal and carrier screening, and pharmacogenomic tests. | Booth Exhibiting at Booth 1061 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Thu Nov 12 12:15–1:30pm Innovations at Myriad Genetics: Firstgene® Multiple Prenatal Screen and Myrisk® with Riskscore® Breast Cancer Risk Assessment Introduces Myriad's FirstGene multiple prenatal screen and updates to its MyRisk breast cancer risk assessment with RiskScore. |
Find buyers from companies at NSGC 2026
Tell us what you sell and we’ll find the people at these companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where was NSGC 2026?
NSGC 45th Annual Conference ran November 10–14, 2026, at the Baltimore Convention Center in Baltimore, MD.
What is NSGC 2026?
The National Society of Genetic Counselors’ 45th Annual Conference, held November 10–14, 2026 at the Baltimore Convention Center, with a virtual day on November 10. About 2,500 genetic counselors and other genetic healthcare professionals attend, from clinics and hospitals, genetic testing laboratories, industry and research. The program runs plenaries, educational sessions, workshops, abstract presentations and poster viewing, sponsored breakfast and lunch symposia, and an exhibit hall.
What is in this guide?
Every organization in the NSGC 2026 exhibit hall — 86 exhibitors with their booth numbers and the hall’s opening hours — and the 18 sponsored breakfast and lunch symposia on the program, each on its sponsor’s row with its day, time and a link to the organizer’s page for it (17 sponsors; 86 organizations in all). The guide does not list the program’s speakers: NSGC’s speaker list gives no employer, which appears only inside each speaker’s biography, so their organizations cannot be placed without reading about each person.
Where does this list come from?
The meeting’s public site: the exhibitor list with the profile each exhibitor published (54 of the 86 exhibitors had written a company description there), and the program, where each sponsored symposium names its sponsor. Short descriptions are condensed from an exhibitor’s profile or its own website, or state what is well established about the organization. Nothing here requires a login.
How are organizations typed?
By what each organization is or offers a genetic counselor: genetic testing laboratories, drug developers (most of them in rare disease), software and digital health companies, other service providers, clinics and hospitals, research institutes and registries, and patient advocacy groups, foundations and professional societies. The topic tags — prenatal and reproductive, hereditary cancer, rare disease and so on — come from an organization’s own exhibitor profile and website, and from the symposium it sponsors, at most three each.
How current is it?
Pulled from the meeting’s public exhibitor list and program on November 12, 2026, during the meeting. Exhibit hall hours are from the program.
Why are there no names?
This guide is about which organizations are in the room, not which people. It never publishes a person’s name.
Browse NSGC 2026 by
Organizations with their own page
86 organizations — every exhibitor and every organization with 1 or more presentations.
- Acadia Pharmaceuticals
- AiLife Diagnostics
- Alexion, AstraZeneca Rare Disease
- Allele Diagnostics
- Ambry Genetics
- American Board of Genetic Counseling
- American Kidney Fund
- American Society of Human Genetics
- Amicus Therapeutics
- Amyloidosis Research Consortium
- Arrowhead Pharmaceuticals
- ARUP Laboratories
- Ascendis Pharma
- Basser Center for BRCA
- Baylor Genetics
- Beren Therapeutics
- BillionToOne
- BioMarin
- BridgeBio
- CancerIQ
- CARE Reproductive Health
- CeGaT
- Centogene
- Chiesi Global Rare Diseases
- ConnectMyVariant
- Coriell Institute for Medical Research
- Down Syndrome Association of Maryland
- Down Syndrome Diagnosis Network
- DuPont Clinic
- Exact Sciences
- FamGenix
- FORCE: Facing Our Risk of Cancer Empowered
- Foundation for Angelman Syndrome Therapeutics
- Fulgent Genetics
- Geisinger
- GeneDx
- Genetic Support Foundation
- GENinCode
- GenomeConnect
- GoPath Diagnostics
- GRAIL
- Greenwood Genetic Center
- Helix
- Hope Clinic
- Hope Story
- Immunovia
- IntraBio
- Ionis Pharmaceuticals
- Jack's Basket
- Jacqueline Rush Foundation
- Kennedy Krieger Institute
- King Center for Lynch Syndrome at Penn Medicine
- Labcorp
- Li-Fraumeni Syndrome Association
- Lilly
- Mighty Therapeutics
- Mirum Pharmaceuticals
- My Faulty Gene
- MyOme
- Myriad Genetics
- Natera
- National Down Syndrome Adoption Network
- National Organization for Disorders of the Corpus Callosum
- Nemours Children's Health
- Parent Project Muscular Dystrophy
- Partners in Abortion Care
- Pfizer
- PKD-Free Alliance
- PLUGS
- PTC Therapeutics
- Quest Diagnostics
- Regeneron
- Revvity
- RISE Collective
- Rising Kites
- Sanofi
- Sharsheret
- Simons Searchlight
- SpringWorks Therapeutics
- Takeda
- The Women's Centers
- UCB
- United Mitochondrial Disease Foundation
- University of Washington
- Valley Community Care (VAG Clinic)
- Variantyx
Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction